SEMA3F and cancer: Several studies have shown that the expression of SEMA3F and its receptors fulfill important regulatory roles in multiple forms of cancer [9], and that the use of treatments aimed at modifying the activity of the SEMA3F-NRP2 axis would have therapeutic potential [10,11].